{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T02:24:53Z","timestamp":1792463093064,"version":"4.5.0"},"reference-count":50,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,7,21]],"date-time":"2025-07-21T00:00:00Z","timestamp":1753056000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pediatr."],"abstract":"<jats:p>Benzoyl peroxide is a widely used and effective topical treatment for acne vulgaris, particularly in pediatric and adolescent populations. Despite its established safety profile, recent concerns emerged regarding its potential to decompose into benzene, a known carcinogen, under specific environmental conditions, like elevated temperatures and exposure to ultraviolet radiation. In this paper we review the management of acne vulgaris in pediatric patients, examine the evidence supporting benzoyl peroxide use and explore the recent studies evaluating the association between benzoyl peroxide use and malignancy risk. While initial reports raised alarm over benzene formation, subsequent investigations have not demonstrated an increased risk of hematologic malignancies. Here, we assess the strengths and limitations of existing evidence and identify future research priorities. Additionally, we provide recommendations for the safe and evidence-based use of benzoyl peroxide in pediatric acne treatment.<\/jats:p>","DOI":"10.3389\/fped.2025.1599491","type":"journal-article","created":{"date-parts":[[2025,7,21]],"date-time":"2025-07-21T05:22:11Z","timestamp":1753075331000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":6,"title":["Benzoyl peroxide in the treatment of acne: are there potential health concerns?"],"prefix":"10.3389","volume":"13","author":[{"given":"Sonia","family":"Czyz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kerry","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatemeh","family":"Jafarian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,7,21]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"5754","DOI":"10.1038\/s41598-020-62715-3","article-title":"Systematic review of the epidemiology of acne vulgaris","volume":"10","author":"Heng","year":"2020","journal-title":"Sci Rep"},{"key":"B2","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1111\/jdv.14475","article-title":"Acne prevalence and associations with lifestyle: a cross-sectional online survey of adolescents\/young adults in 7 European countries","volume":"32","author":"Wolkenstein","year":"2018","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"B3","doi-asserted-by":"publisher","first-page":"S34","DOI":"10.1016\/S0190-9622(98)70442-6","article-title":"Recent findings in the epidemiologic evidence, classification, and subtypes of acne vulgaris","volume":"39","author":"White","year":"1998","journal-title":"J Am Acad Dermatol"},{"key":"B4","doi-asserted-by":"publisher","first-page":"21084","DOI":"10.1038\/s41598-023-48182-6","article-title":"Understanding the impact of acne vulgaris and associated psychological distress on self-esteem and quality of life via regression modeling with CADI, DLQI, and WHOQoL","volume":"13","author":"Morshed","year":"2023","journal-title":"Sci Rep"},{"key":"B5","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1007\/s13555-018-0224-7","article-title":"A qualitative investigation of the impact of acne on health-related quality of life (HRQL): development of a conceptual model","volume":"8","author":"Fabbrocini","year":"2018","journal-title":"Dermatol Ther (Heidelb)"},{"key":"B6","doi-asserted-by":"publisher","first-page":"37702","DOI":"10.1289\/EHP13984","article-title":"Benzoyl peroxide drug products form benzene","volume":"132","author":"Kucera","year":"2024","journal-title":"Environ Health Perspect"},{"key":"B7","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.1001\/archderm.1992.01680200055006","article-title":"Sebaceous gland activity and serum dehydroepiandrosterone sulfate levels in boys and girls","volume":"128","author":"Stewart","year":"1992","journal-title":"Arch Dermatol"},{"key":"B8","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1111\/j.1365-2133.2012.10897.x","article-title":"An increased incidence of propionibacterium acnes biofilms in acne vulgaris: a case-control study","volume":"167","author":"Jahns","year":"2012","journal-title":"Br J Dermatol"},{"key":"B9","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1111\/jdv.18794","article-title":"Recent advances in understanding inflammatory acne: deciphering the relationship between cutibacterium acnes and Th17 inflammatory pathway","volume":"37","author":"Mias","year":"2023","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"B10","doi-asserted-by":"publisher","first-page":"S163","DOI":"10.1542\/peds.2013-0490B","article-title":"Evidence-based recommendations for the diagnosis and treatment of pediatric acne","volume":"131","author":"Eichenfield","year":"2013","journal-title":"Pediatrics"},{"key":"B11","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1111\/pde.15166","article-title":"Pathologic acne in pre-pubertal children: a case series and review on when to refer to pediatric endocrinology","volume":"40","author":"Shope","year":"2023","journal-title":"Pediatr Dermatol"},{"key":"B12","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1111\/j.1525-1470.2011.01643.x","article-title":"Changing age of acne vulgaris visits: another sign of earlier puberty?","volume":"28","author":"Goldberg","year":"2011","journal-title":"Pediatr Dermatol"},{"key":"B13","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1007\/s40257-019-00423-z","article-title":"Topical retinoids in acne vulgaris: a systematic review","volume":"20","author":"Kolli","year":"2019","journal-title":"Am J Clin Dermatol"},{"key":"B14","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1111\/j.1365-4362.1986.tb04534.x","article-title":"Comparing 2.5%, 5%, and 10% benzoyl peroxide on inflammatory acne vulgaris","volume":"25","author":"Mills","year":"1986","journal-title":"Int J Dermatol"},{"key":"B15","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1016\/S0190-9622(97)70177-4","article-title":"Treatment of acne with a combination clindamycin\/benzoyl peroxide gel compared with clindamycin gel, benzoyl peroxide gel and vehicle gel: combined results of two double-blind investigations","volume":"37","author":"Lookingbill","year":"1997","journal-title":"J Am Acad Dermatol"},{"key":"B16","doi-asserted-by":"publisher","first-page":"1006.e1","DOI":"10.1016\/j.jaad.2023.12.017","article-title":"Guidelines of care for the management of acne vulgaris","volume":"90","author":"Reynolds","year":"2024","journal-title":"J Am Acad Dermatol"},{"key":"B17","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.clindermatol.2016.10.008","article-title":"Propionibacterium acnes and antimicrobial resistance in acne","volume":"35","author":"Dessinioti","year":"2017","journal-title":"Clin Dermatol"},{"key":"B18","first-page":"417","article-title":"Antibiotic-resistant propionibacterium acnes suppressed by a benzoyl peroxide cleanser 6%","volume":"82","author":"Leyden","year":"2008","journal-title":"Cutis"},{"key":"B19","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1007\/s00403-007-0777-2","article-title":"Treatment of acne with intermittent and conventional isotretinoin: a randomized, controlled multicenter study","volume":"299","author":"Akman","year":"2007","journal-title":"Arch Dermatol Res"},{"key":"B20","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1016\/j.jaad.2005.11.1061","article-title":"Low-dose isotretinoin in the treatment of acne vulgaris","volume":"54","author":"Amichai","year":"2006","journal-title":"J Am Acad Dermatol"},{"key":"B21","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1016\/j.pdj.2020.08.003","article-title":"Tetracycline use in children and knowledge of its oral implications among nursing mothers","volume":"30","author":"Enabulele","year":"2020","journal-title":"Pediatr Dent J"},{"key":"B22","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1111\/j.1365-4632.2004.02108.x","article-title":"Tetracycline and other tetracycline-derivative staining of the teeth and oral cavity","volume":"43","author":"S\u00e1nchez","year":"2004","journal-title":"Int J Dermatol"},{"key":"B23","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/S0190-9622(81)70004-5","article-title":"Benzoyl peroxide: percutaneous penetration and metabolic disposition","volume":"4","author":"Nacht","year":"1981","journal-title":"J Am Acad Dermatol"},{"key":"B24","doi-asserted-by":"publisher","first-page":"e15288","DOI":"10.1111\/dth.15288","article-title":"The influence of benzoyl peroxide on skin microbiota and the epidermal barrier for acne vulgaris","volume":"35","author":"Zhou","year":"2022","journal-title":"Dermatol Ther"},{"key":"B25","doi-asserted-by":"publisher","first-page":"54","DOI":"10.36849\/JDD.7150","article-title":"Sixty years of benzoyl peroxide use in dermatology","volume":"22","author":"Baldwin","year":"2023","journal-title":"J Drugs Dermatol"},{"key":"B26","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.1111\/jdv.13776","article-title":"European evidence-based (S3) guideline for the treatment of acne\u2014update 2016\u2014short version","volume":"30","author":"Nast","year":"2016","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"B27","first-page":"21","article-title":"A three-step acne system containing solubilized benzoyl peroxide versus benzoyl peroxide\/clindamycin in pediatric patients with acne","volume":"2","author":"Eichenfield","year":"2009","journal-title":"J Clin Aesthet Dermatol"},{"key":"B28","first-page":"1395","article-title":"Treatment of 2,453 acne vulgaris patients aged 12\u201317 years with the fixed-dose Adapalene-benzoyl peroxide combination topical gel: efficacy and safety","volume":"9","author":"Eichenfield","year":"2010","journal-title":"J Drugs Dermatol"},{"key":"B29","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1111\/pde.15283","article-title":"Triple-combination clindamycin phosphate 1.2%\/benzoyl peroxide 3.1%\/Adapalene 0.15% gel for moderate-to-severe acne in children and adolescents: randomized phase 2 study","volume":"40","author":"Eichenfield","year":"2023","journal-title":"Pediatr Dermatol"},{"key":"B30","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1016\/j.jaad.2023.05.093","article-title":"Efficacy and safety of microencapsulated benzoyl peroxide and microencapsulated tretinoin for the treatment of acne vulgaris: results from two phase 3 double-blind, randomized, vehicle-controlled studies","volume":"89","author":"Del Rosso","year":"2023","journal-title":"J Am Acad Dermatol"},{"key":"B31","doi-asserted-by":"publisher","first-page":"1180","DOI":"10.1111\/j.1365-2133.2009.09209.x","article-title":"Adapalene-benzoyl peroxide, a unique fixed-dose combination topical gel for the treatment of acne vulgaris: a transatlantic, randomized, double-blind, controlled study in 1670 patients","volume":"161","author":"Gollnick","year":"2009","journal-title":"Br J Dermatol"},{"key":"B32","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1111\/1346-8138.13741","article-title":"Open-label, randomized, multicenter, phase III study to evaluate the safety and efficacy of benzoyl peroxide gel in long-term use in patients with acne vulgaris: a secondary publication","volume":"44","author":"Kawashima","year":"2017","journal-title":"J Dermatol"},{"key":"B33","first-page":"28","article-title":"Efficacy and tolerability of a fixed combination of clindamycin phosphate (1.2%) and benzoyl peroxide (3.75%) aqueous gel in moderate or severe adolescent acne vulgaris","volume":"8","author":"Cook-Bolden","year":"2015","journal-title":"J Clin Aesthet Dermatol"},{"key":"B34","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1111\/1346-8138.13798","article-title":"Twelve-week, multicenter, placebo-controlled, randomized, double-blind, parallel-group, comparative phase II\/III study of benzoyl peroxide gel in patients with acne vulgaris: a secondary publication","volume":"44","author":"Kawashima","year":"2017","journal-title":"J Dermatol"},{"key":"B35","first-page":"582","article-title":"Adapalene\/benzoyl peroxide gel 0.3%\/2.5%: effective acne therapy regardless of age or gender","volume":"16","author":"Gold","year":"2017","journal-title":"J Drugs Dermatol"},{"key":"B36","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1111\/pde.13741","article-title":"The microbiome in preadolescent acne: assessment and prospective analysis of the influence of benzoyl peroxide","volume":"36","author":"Ahluwalia","year":"2019","journal-title":"Pediatr Dermatol"},{"key":"B37","doi-asserted-by":"publisher","first-page":"920","DOI":"10.1016\/S0190-9622(83)70209-4","article-title":"Benzoyl peroxide: percutaneous penetration and metabolic disposition. II. Effect of concentration","volume":"9","author":"Yeung","year":"1983","journal-title":"J Am Acad Dermatol"},{"key":"B38","volume-title":"Valisure Citizen Petition on Benzene in Benzoyl Peroxide Drug Products","year":"2024"},{"key":"B39","volume-title":"Academy Response to Benzene Petition on Benzoyl Peroxide Products [Press Release]","author":"Homiston","year":"2024"},{"key":"B40","volume-title":"Response Statement from the American Acne & Rosacea Society to the Valisure Citizen Petition on Benzene in Benzoyl Peroxide Drug Products","year":"2024"},{"key":"B41","doi-asserted-by":"publisher","first-page":"3","DOI":"10.12788\/cutis.1043","article-title":"Benzoyl peroxide, benzene, and lots of unanswered questions: where are we now?","volume":"114","author":"Del Rosso","year":"2024","journal-title":"Cutis"},{"key":"B42","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1016\/j.jaad.2024.04.064","article-title":"Benzoyl peroxide use in acne therapy: evaluating the association with acute myeloid leukemia risk","volume":"91","author":"Veenstra","year":"2024","journal-title":"J Am Acad Dermatol"},{"key":"B43","doi-asserted-by":"publisher","first-page":"e109","DOI":"10.1016\/j.jaad.2024.05.090","article-title":"Response to veenstra et al\u2019s \u201cbenzoyl peroxide use in acne therapy: evaluating the association with acute myeloid leukemia risk\u201d","volume":"91","author":"Barbieri","year":"2024","journal-title":"J Am Acad Dermatol"},{"key":"B44","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1016\/j.jaad.2024.06.050","article-title":"No evidence for an association between benzoyl peroxide use and increased blood benzene levels in the national health and nutrition examination survey","volume":"91","author":"Sadr","year":"2024","journal-title":"J Am Acad Dermatol"},{"key":"B45","doi-asserted-by":"publisher","first-page":"966","DOI":"10.1016\/j.jaad.2024.07.011","article-title":"Benzoyl peroxide for acne treatment is not associated with an increased risk of malignancy: a retrospective cohort study","volume":"91","author":"Garate","year":"2024","journal-title":"J Am Acad Dermatol"},{"key":"B46","doi-asserted-by":"publisher","first-page":"1234","DOI":"10.1016\/j.jaad.2024.07.1504","article-title":"No association of benzoyl peroxide use with acute myeloid leukemia and hematologic malignancies in a multi-center retrospective study","volume":"91","author":"Chan","year":"2024","journal-title":"J Am Acad Dermatol"},{"key":"B47","first-page":"AB18","article-title":"Impact of acne on teens: results from harris interactive poll","volume":"60","year":"2009","journal-title":"J Am Acad Dermatol"},{"key":"B48","doi-asserted-by":"publisher","first-page":"00300","DOI":"10.1016\/j.jid.2025.02.139","article-title":"A disproportionality analysis on benzoyl peroxide and its risk of malignancy using the FDA adverse event reporting system","author":"Yang","year":"2025","journal-title":"J Invest Dermatol"},{"key":"B49","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1016\/j.jid.2024.09.009","article-title":"Evaluation of benzene presence and formation in benzoyl peroxide drug products","volume":"145","author":"Kucera","year":"2024","journal-title":"J Invest Dermatol"},{"key":"B50","article-title":"Classification of benzoyl peroxide as safe and effective and revision of labeling to drug facts format","year":"2010"}],"container-title":["Frontiers in Pediatrics"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fped.2025.1599491\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,21]],"date-time":"2025-07-21T05:22:14Z","timestamp":1753075334000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fped.2025.1599491\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,21]]},"references-count":50,"alternative-id":["10.3389\/fped.2025.1599491"],"URL":"https:\/\/doi.org\/10.3389\/fped.2025.1599491","relation":{},"ISSN":["2296-2360"],"issn-type":[{"value":"2296-2360","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,21]]},"article-number":"1599491"}}